PHELINUN Powder and solvent for solution for infusion Ref.[49918] Active ingredients: Melphalan

Source: European Medicines Agency (EU)  Revision Year: 2021  Publisher: ADIENNE S.r.l. S.U., Via Galileo Galilei, 19, 20867 Caponago (MB), Italy, tel: +39 0240700445, e-mail: adienne@adienne.com

Product name and form

PHELINUN 50 mg powder and solvent for concentrate for solution for infusion.

PHELINUN 200 mg powder and solvent for concentrate for solution for infusion.

Pharmaceutical Form

Powder and solvent for concentrate for solution for infusion.

Powder: white to pale yellow freeze-dried powder or cake.

Solvent: clear colourless liquid solution.

The pH of the reconstituted solution is between 6.0 and 7.0 and the osmolality is 75 mOsmol/kg.

Qualitative and quantitative composition

PHELINUN 50 mg powder and solvent for concentrate for solution for infusion

One vial of powder for concentrate for solution for infusion contains 50 mg melphalan (as melphalan hydrochloride).

After reconstitution with 10 ml of solvent, the final concentration of the solution is 5 mg/ml.

Excipients with known effect: When reconstituted, one vial contains 0.68 mmol (15.63 mg) of sodium, 400 mg of ethanol and 6.2 g of propylene glycol.

PHELINUN 200 mg powder and solvent for concentrate for solution for infusion

One vial of powder for concentrate for solution for infusion contains 200 mg melphalan (as melphalan hydrochloride).

After reconstitution with 40 ml of solvent, the final concentration of the solution is 5 mg/ml.

Excipients with known effect: When reconstituted, one vial contains 2.72 mmol (62.52 mg) of sodium, 1.6 g of ethanol and 24.9 g of propylene glycol.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Melphalan

Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication.

List of Excipients

Powder:

Hydrochloric acid (pH adjustment)
Povidone

Solvent:

Water for injections
Propylene glycol
Ethanol
Sodium citrate

Pack sizes and marketing

Powder: Type I glass vial closed with coated chlorobutyl rubber stopper and sealed with aluminium flip-off cap.

Solvent: Type I glass vial closed with coated chlorobutyl rubber stopper and sealed with aluminium flip-off cap.

Pack size: one vial containing 50 mg or 200 mg melphalan and one vial containing 10 ml or 40 ml of solvent.

Marketing authorization holder

ADIENNE S.r.l. S.U., Via Galileo Galilei, 19, 20867 Caponago (MB), Italy, tel: +39 0240700445, e-mail: adienne@adienne.com

Marketing authorization dates and numbers

EU/1/20/1487/001
EU/1/20/1487/002

Date of first authorisation: 17 November 2020

Drugs

Drug Countries
PHELINUN Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.